| Year |
Citation |
Score |
| 2024 |
Liu YN, Chen WY, Liu MK, Yeh HL, Chen WH, Jiang KC, Li HR, Chen ZQ, Wang WH, Abou-Kheir W, Wen YC. Immunosuppressive role of BDNF in therapy-induced neuroendocrine prostate cancer. Molecular Oncology. PMID 38381121 DOI: 10.1002/1878-0261.13614 |
0.352 |
|
| 2021 |
El-Soussi S, Hanna R, Semaan H, Khater AR, Abdallah J, Abou-Kheir W, Abou-Antoun T. A Novel Therapeutic Mechanism of Imipridones ONC201/ONC206 in MYCN-Amplified Neuroblastoma Cells Differential Expression of Tumorigenic Proteins. Frontiers in Pediatrics. 9: 693145. PMID 34422720 DOI: 10.3389/fped.2021.693145 |
0.307 |
|
| 2021 |
Bahmad HF, Jalloul M, Azar J, Moubarak MM, Samad TA, Mukherji D, Al-Sayegh M, Abou-Kheir W. Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development. Frontiers in Genetics. 12: 652747. PMID 33841508 DOI: 10.3389/fgene.2021.652747 |
0.337 |
|
| 2021 |
Jaafar L, Fakhoury I, Saab S, El-Hajjar L, Abou-Kheir W, El-Sibai M. StarD13 differentially regulates migration and invasion in prostate cancer cells. Human Cell. PMID 33420961 DOI: 10.1007/s13577-020-00479-8 |
0.348 |
|
| 2020 |
Cheaito K, Bahmad HF, Jalloul H, Hadadeh O, Msheik H, El-Hajj A, Mukherji D, Al-Sayegh M, Abou-Kheir W. Epidermal Growth Factor Is Essential for the Maintenance of Novel Prostate Epithelial Cells Isolated From Patient-Derived Organoids. Frontiers in Cell and Developmental Biology. 8: 571677. PMID 33195205 DOI: 10.3389/fcell.2020.571677 |
0.353 |
|
| 2020 |
Bou-Gharios J, Assi S, Bahmad HF, Kharroubi H, Araji T, Chalhoub RM, Ballout F, Harati H, Fares Y, Abou-Kheir W. The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells. Pharmacological Reports : Pr. PMID 33140310 DOI: 10.1007/s43440-020-00180-5 |
0.32 |
|
| 2020 |
Bahmad HF, Elajami MK, Daouk R, Jalloul H, Darwish B, Chalhoub RM, Assi S, Chamaa F, Abou-Kheir W. Stem Cells: In Sickness and in Health. Current Stem Cell Research & Therapy. PMID 32867660 DOI: 10.2174/1574888X15999200831160710 |
0.374 |
|
| 2020 |
Ballout F, Monzer A, Fatfat M, Ouweini HE, Jaffa MA, Abdel-Samad R, Darwiche N, Abou-Kheir W, Gali-Muhtasib H. Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem/progenitor cells. Oncotarget. 11: 2959-2972. PMID 32821342 DOI: 10.18632/Oncotarget.27426 |
0.425 |
|
| 2020 |
Daouk R, Bahmad HF, Saleh E, Monzer A, Ballout F, Kadara H, Abou-Kheir W. Genome-wide gene expression analysis of a murine model of prostate cancer progression: Deciphering the roles of IL-6 and p38 MAPK as potential therapeutic targets. Plos One. 15: e0237442. PMID 32790767 DOI: 10.1371/Journal.Pone.0237442 |
0.401 |
|
| 2020 |
Bahmad HF, Peng W, Zhu R, Ballout F, Monzer A, Elajami MK, Kobeissy F, Abou-Kheir W, Mechref Y. Protein Expression Analysis of an In Vitro Murine Model of Prostate Cancer Progression: Towards Identification of High-Potential Therapeutic Targets. Journal of Personalized Medicine. 10. PMID 32784957 DOI: 10.3390/Jpm10030083 |
0.384 |
|
| 2020 |
Bahmad HF, Abou-Kheir W. Crosstalk between COVID-19 and prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 32709978 DOI: 10.1038/S41391-020-0262-Y |
0.377 |
|
| 2020 |
Al Matari N, Deeb G, Mshiek H, Sinjab A, Kadara H, Abou-Kheir W, Mhanna R. Anti-Tumor Effects of Biomimetic Sulfated Glycosaminoglycans on Lung Adenocarcinoma Cells in 2D and 3D In Vitro Models. Molecules (Basel, Switzerland). 25. PMID 32503108 DOI: 10.3390/Molecules25112595 |
0.414 |
|
| 2020 |
Msheik H, Azar J, El Sabeh M, Abou-Kheir W, Daoud G. HTR-8/SVneo: A model for epithelial to mesenchymal transition in the human placenta. Placenta. 90: 90-97. PMID 32056558 DOI: 10.1016/J.Placenta.2019.12.013 |
0.362 |
|
| 2020 |
Bahmad HF, Elajami MK, El Zarif T, Bou-Gharios J, Abou-Antoun T, Abou-Kheir W. Drug repurposing towards targeting cancer stem cells in pediatric brain tumors. Cancer Metastasis Reviews. PMID 31919619 DOI: 10.1007/S10555-019-09840-2 |
0.356 |
|
| 2020 |
Hanna R, Daouk R, Ballout F, El-Soussie S, Abdallah J, Abou-Kheir W, Abou-Antoun TM. Abstract 3797: Anti-cancer effects of novel imipridone DRD2 antagonists in a panel of human cancer cell lines Cancer Research. 80: 3797-3797. DOI: 10.1158/1538-7445.Am2020-3797 |
0.455 |
|
| 2019 |
Msheik H, El Hayek S, Bari MF, Azar J, Abou-Kheir W, Kobeissy F, Vatish M, Daoud G. Transcriptomic Profiling of Trophoblast Fusion Using BeWo and JEG-3 Cell Lines. Molecular Human Reproduction. PMID 31778538 DOI: 10.1093/Molehr/Gaz061 |
0.357 |
|
| 2019 |
Malaeb W, Bahmad HF, Abou-Kheir W, Mhanna R. The sulfation of biomimetic glycosaminoglycan substrates controls binding of growth factors and subsequent neural and glial cell growth. Biomaterials Science. PMID 31407727 DOI: 10.1039/C9Bm00964G |
0.308 |
|
| 2019 |
Darwish B, Chamaa F, Al-Chaer ED, Saadé NE, Abou-Kheir W. Intranigral Injection of Endotoxin Suppresses Proliferation of Hippocampal Progenitor Cells. Frontiers in Neuroscience. 13: 687. PMID 31333405 DOI: 10.3389/Fnins.2019.00687 |
0.313 |
|
| 2019 |
Bahmad HF, Chamaa F, Assi S, Chalhoub RM, Abou-Antoun T, Abou-Kheir W. Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier. Frontiers in Molecular Neuroscience. 12: 131. PMID 31191243 DOI: 10.3389/Fnmol.2019.00131 |
0.384 |
|
| 2019 |
Daouk R, Hassane M, Bahmad HF, Sinjab A, Fujimoto J, Abou-Kheir W, Kadara H. Genome-Wide and Phenotypic Evaluation of Stem Cell Progenitors Derived From -Deficient Murine Lung Adenocarcinoma With Somatic Mutations. Frontiers in Oncology. 9: 207. PMID 31001473 DOI: 10.3389/Fonc.2019.00207 |
0.387 |
|
| 2019 |
Bodgi L, Bahmad HF, Araji T, Al Choboq J, Bou-Gharios J, Cheaito K, Zeidan YH, Eid T, Geara F, Abou-Kheir W. Assessing Radiosensitivity of Bladder Cancer : A 2D vs. 3D Approach. Frontiers in Oncology. 9: 153. PMID 30941305 DOI: 10.3389/Fonc.2019.00153 |
0.366 |
|
| 2019 |
Cheaito KA, Bahmad HF, Hadadeh O, Saleh E, Dagher C, Hammoud MS, Shahait M, Mrad ZA, Nassif S, Tawil A, Bulbul M, Khauli R, Wazzan W, Nasr R, Shamseddine A, ... ... Abou-Kheir W, et al. EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence? Frontiers in Oncology. 9: 131. PMID 30915272 DOI: 10.3389/Fonc.2019.00131 |
0.352 |
|
| 2019 |
Bahmad HF, Samman H, Monzer A, Hadadeh O, Cheaito K, Abdel-Samad R, Hayar B, Pisano C, Msheik H, Liu YN, Darwiche N, Abou-Kheir W. The synthetic retinoid ST1926 attenuates prostate cancer growth and potentially targets prostate cancer stem-like cells. Molecular Carcinogenesis. PMID 30883933 DOI: 10.1002/Mc.23004 |
0.483 |
|
| 2018 |
Bahmad HF, Mouhieddine TH, Chalhoub RM, Assi S, Araji T, Chamaa F, Itani MM, Nokkari A, Kobeissy F, Daoud G, Abou-Kheir W. The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma. Oncotarget. 9: 33549-33561. PMID 30323898 DOI: 10.18632/Oncotarget.26088 |
0.433 |
|
| 2018 |
Bahmad HF, Cheaito K, Chalhoub RM, Hadadeh O, Monzer A, Ballout F, El-Hajj A, Mukherji D, Liu YN, Daoud G, Abou-Kheir W. Sphere-Formation Assay: Three-Dimensional Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells. Frontiers in Oncology. 8: 347. PMID 30211124 DOI: 10.3389/Fonc.2018.00347 |
0.445 |
|
| 2018 |
Siu MK, Abou-Kheir W, Yin JJ, Chang YS, Barrett B, Suau F, Casey O, Chen WY, Fang L, Hynes P, Hsieh YY, Liu YN, Huang J, Kelly K. Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance. Oncotarget. 9: 32403. PMID 30190798 DOI: 10.18632/Oncotarget.26020 |
0.348 |
|
| 2018 |
Chamaa F, Bahmad HF, Makkawi AK, Chalhoub RM, Al-Chaer ED, Bikhazi GB, Nahas Z, Abou-Kheir W. Nitrous Oxide Induces Prominent Cell Proliferation in Adult Rat Hippocampal Dentate Gyrus. Frontiers in Cellular Neuroscience. 12: 135. PMID 29867368 DOI: 10.3389/Fncel.2018.00135 |
0.315 |
|
| 2018 |
Tsai YC, Chen WY, Abou-Kheir W, Zeng T, Yin JJ, Bahmad H, Lee YC, Liu YN. Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2. Biochimica Et Biophysica Acta. PMID 29477409 DOI: 10.1016/J.Bbadis.2018.02.016 |
0.433 |
|
| 2018 |
Tsai YC, Zeng T, Abou-Kheir W, Yeh HL, Yin JJ, Lee YC, Chen WY, Liu YN. Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer. Molecular Cancer. 17: 42. PMID 29455655 DOI: 10.1186/S12943-018-0785-1 |
0.375 |
|
| 2018 |
Cheaito KA, Hadadeh O, Bahmad H, El-Sabban M, El-Hajj A, Mukherji D, Abou-Kheir W. Abstract B090: Personalized research: Establishment and characterization of prostate cancer patient-derived organoids and cells Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-B090 |
0.447 |
|
| 2018 |
Ballout FR, Fatfat M, Abdel-Samad R, Darwiche N, Schneider-Stock R, Abou-Kheir W, Muhtasib H. Abstract 170: Targeting colorectal cancer stem cells with the anticancer molecule thymoquinone Cancer Research. 78: 170-170. DOI: 10.1158/1538-7445.Am2018-170 |
0.43 |
|
| 2017 |
Bilani N, Bahmad H, Abou-Kheir W. Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms. Frontiers in Pharmacology. 8: 145. PMID 28377721 DOI: 10.3389/Fphar.2017.00145 |
0.389 |
|
| 2017 |
Bahmad H, Hadadeh O, Chamaa F, Cheaito K, Darwish B, Makkawi AK, Abou-Kheir W. Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma. Frontiers in Molecular Neuroscience. 10: 50. PMID 28293168 DOI: 10.3389/Fnmol.2017.00050 |
0.353 |
|
| 2017 |
Katerji M, Barada K, Jomaa M, Kobeissy F, Makkawi AK, Abou-Kheir W, Usta J. Chemosensitivity of U251 Cells to the Co-treatment of D-Penicillamine and Copper: Possible Implications on Wilson Disease Patients. Frontiers in Molecular Neuroscience. 10: 10. PMID 28197071 DOI: 10.3389/Fnmol.2017.00010 |
0.308 |
|
| 2017 |
Abou-Kheir W, Barrak J, Hadadeh O, Daoud G. HTR-8/SVneo cell line contains a mixed population of cells. Placenta. 50: 1-7. PMID 28161053 DOI: 10.1016/J.Placenta.2016.12.007 |
0.371 |
|
| 2016 |
Daoud G, Monzer A, Bahmad H, Chamaa F, Hamdar L, Mouhieddine TH, Shayya S, Eid A, Kobeissy F, Liu YN, Abou-Kheir W. Primary versus castration‑resistant prostate cancer: modeling through novel murine prostate cancer cell lines. Oncotarget. PMID 27036046 DOI: 10.18632/Oncotarget.8436 |
0.46 |
|
| 2016 |
Barrak J, Msheik H, Abou-Kheir W, Daoud G. Assessment of different trophoblast cell lines as in vitro models for placental development Placenta. 45: 106. DOI: 10.1016/J.Placenta.2016.06.157 |
0.32 |
|
| 2015 |
Mouhieddine TH, Nokkari A, Itani MM, Chamaa F, Bahmad H, Monzer A, El-Merahbi R, Daoud G, Eid A, Kobeissy FH, Abou-Kheir W. Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells. Frontiers in Neuroscience. 9: 442. PMID 26635517 DOI: 10.3389/Fnins.2015.00442 |
0.422 |
|
| 2015 |
Agarwal S, Hynes PG, Tillman HS, Lake R, Abou-Kheir WG, Fang L, Casey OM, Ameri AH, Martin PL, Yin JJ, Iaquinta PJ, Karthaus WR, Clevers HC, Sawyers CL, Kelly K. Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors. Cell Reports. 13: 2147-58. PMID 26628377 DOI: 10.1016/J.Celrep.2015.10.077 |
0.309 |
|
| 2015 |
Abou-Kheir W, Eid A, El-Merahbi R, Assaf R, Daoud G. A Unique Expression of Keratin 14 in a Subset of Trophoblast Cells. Plos One. 10: e0139939. PMID 26430881 DOI: 10.1371/Journal.Pone.0139939 |
0.396 |
|
| 2015 |
Nokkari A, Mouhieddine TH, Itani MM, Abou-Kheir W, Daoud G, Zhu R, Meshref Y, Soueid J, Al Hariri M, Mondello S, Jaffa AA, Kobeissy F. Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment. Plos One. 10: e0128601. PMID 26047500 DOI: 10.1371/Journal.Pone.0128601 |
0.34 |
|
| 2015 |
Chen WY, Liu SY, Chang YS, Yin JJ, Yeh HL, Mouhieddine TH, Hadadeh O, Abou-Kheir W, Liu YN. MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer. Oncotarget. 6: 441-57. PMID 25436980 DOI: 10.18632/Oncotarget.2690 |
0.365 |
|
| 2014 |
El-Merahbi R, Liu YN, Eid A, Daoud G, Hosry L, Monzer A, Mouhieddine TH, Hamade A, Najjar F, Abou-Kheir W. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells. Plos One. 9: e112453. PMID 25380390 DOI: 10.1371/Journal.Pone.0112453 |
0.458 |
|
| 2014 |
Siu MK, Abou-Kheir W, Yin JJ, Chang YS, Barrett B, Suau F, Casey O, Chen WY, Fang L, Hynes P, Hsieh YY, Liu YN, Huang J, Kelly K. Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance. Oncotarget. 5: 3770-84. PMID 25004126 DOI: 10.18632/Oncotarget.1994 |
0.379 |
|
| 2014 |
Abou-Kheir W, Mouhieddine TH, Itani MM, Liu Y. Bone metastatic prostate cancer and resistance to tyrosine kinase inhibitors: an intimate relationship between loss of miR-203 and up-regulation of EGFR signaling Rna & Disease. 1. DOI: 10.14800/Rd.345 |
0.359 |
|
| 2013 |
Liu YN, Yin JJ, Abou-Kheir W, Hynes PG, Casey OM, Fang L, Yi M, Stephens RM, Seng V, Sheppard-Tillman H, Martin P, Kelly K. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms Oncogene. 32: 296-306. PMID 22370643 DOI: 10.1038/Onc.2012.58 |
0.304 |
|
| 2012 |
Casey OM, Fang L, Hynes PG, Abou-Kheir WG, Martin PL, Tillman HS, Petrovics G, Awwad HO, Ward Y, Lake R, Zhang L, Kelly K. TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation. Plos One. 7: e41668. PMID 22860005 DOI: 10.1371/journal.pone.0041668 |
0.329 |
|
| 2012 |
Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O, Hu D, Wan Y, Seng V, Sheppard-Tillman H, Martin P, Kelly K. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition. Molecular and Cellular Biology. 32: 941-53. PMID 22203039 DOI: 10.1128/Mcb.06306-11 |
0.409 |
|
| 2012 |
Abou-Kheir W, Hynes P, Martin P, Yin J, Liu Y, Seng V, Lake R, Spurrier J, Kelly K. Abstract C66: Establishing clinically relevant in vitro models of prostate cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Prca2012-C66 |
0.455 |
|
| 2012 |
Liu Y, Yin JJ, Abou-Kheir W, Hynes P, Casey O, Martin P, Kathleen K. Abstract B53: MiR-1 inhibits EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms Cancer Research. 72. DOI: 10.1158/1538-7445.Prca2012-B53 |
0.323 |
|
| 2012 |
Liu Y, Martin P, Kelly K, Yin JJ, Abou-Kheir W, Hynes P, Fang L, Casey O, Yi M, Seng V, Tillman H. Abstract A34: Critical and reciprocal regulation of SLUG-KLF4 and SLUG-miR-1/miR-200b in TGFβ-initiated prostate cancer EMT Cancer Research. 72. DOI: 10.1158/1538-7445.Prca2012-A34 |
0.359 |
|
| 2011 |
Abou-Kheir W, Hynes PG, Martin P, Yin JJ, Liu YN, Seng V, Lake R, Spurrier J, Kelly K. Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity. Plos One. 6: e26112. PMID 22022528 DOI: 10.1371/Journal.Pone.0026112 |
0.47 |
|
| 2011 |
Martin P, Liu YN, Pierce R, Abou-Kheir W, Casey O, Seng V, Camacho D, Simpson RM, Kelly K. Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition. The American Journal of Pathology. 179: 422-35. PMID 21703421 DOI: 10.1016/J.Ajpath.2011.03.035 |
0.405 |
|
| 2010 |
Abou-Kheir WG, Hynes PG, Martin PL, Pierce R, Kelly K. Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model. Stem Cells (Dayton, Ohio). 28: 2129-40. PMID 20936707 DOI: 10.1002/stem.538 |
0.345 |
|
| 2009 |
Dovas A, Gevrey JC, Grossi A, Park H, Abou-Kheir W, Cox D. Regulation of podosome dynamics by WASp phosphorylation: implication in matrix degradation and chemotaxis in macrophages. Journal of Cell Science. 122: 3873-82. PMID 19808890 DOI: 10.1242/Jcs.051755 |
0.492 |
|
| 2008 |
Abou-Kheir W, Isaac B, Yamaguchi H, Cox D. Membrane targeting of WAVE2 is not sufficient for WAVE2-dependent actin polymerization: a role for IRSp53 in mediating the interaction between Rac and WAVE2. Journal of Cell Science. 121: 379-90. PMID 18198193 DOI: 10.1242/Jcs.010272 |
0.485 |
|
| Show low-probability matches. |